TY - JOUR
T1 - Left ventricular structure and systolic function in African Americans
T2 - The Atherosclerosis Risk in Communities (ARIC) study
AU - Nkomo, Vuyisile T.
AU - Arnett, Donna K.
AU - Benjamin, Emelia J.
AU - Liebson, Philip R.
AU - Hutchinson, Richard G.
AU - Skelton, Thomas N.
PY - 2004/9
Y1 - 2004/9
N2 - Objectives: To estimate prevalence of left ventricular (LV) hypertrophy and its relation to systolic function in a population-based sample of African Americans. Design: A baseline 2D guided M-mode echocardiogram was conducted as part of a longitudinal cohort study to assess prevalence and cross-sectional relationships between echocardiographic and clinical parameters. Setting: Data were collected as part of the Atherosclerosis Risk in Communities study. Participants: Analysis is limited to 1543 African Americans, aged 51-70 years, without clinically apparent cardiovascular or echocardiographically determined valvular disease. Main Outcome Measures: LV hypertrophy prevalence was defined as LV mass/height2.7≥51 g/m2.7 LV systolic chamber function was assessed at the midwall using the ratio of observed midwall fractional shortening (MWS%) to the value predicted from circumferential end-systolic stress. Results: The prevalence of LV hypertrophy was 33% in men, 38% in women. The prevalence of concentric hypertrophy (LV hypertrophy with relative wall thickness ≥0.45) was greater than that of eccentric hypertrophy (men: 24% vs 9%; women: 27% vs 11% women). Observed/predicted (O/P) MWS% was strongly and inversely related to LV mass/height2.7 (P<.001) and LV hypertrophy (P<001). The O/P MWS% was inversely related to LV mass/height2.7 quartile: O/P MWS% was 106% and 99% in the first and 97% and 89% in the fourth quartile of LV mass/height2.7 for men and women, respectively. Adjusting for age, adiposity, diabetes, blood pressure, antihypertensive medication use, and smoking did not remove association between O/P MWS% and LV mass/height2.7. Conclusions: LV hypertrophy was highly prevalent in this population-based middle-aged sample of African Americans and was associated with poorer LV systolic chamber function.
AB - Objectives: To estimate prevalence of left ventricular (LV) hypertrophy and its relation to systolic function in a population-based sample of African Americans. Design: A baseline 2D guided M-mode echocardiogram was conducted as part of a longitudinal cohort study to assess prevalence and cross-sectional relationships between echocardiographic and clinical parameters. Setting: Data were collected as part of the Atherosclerosis Risk in Communities study. Participants: Analysis is limited to 1543 African Americans, aged 51-70 years, without clinically apparent cardiovascular or echocardiographically determined valvular disease. Main Outcome Measures: LV hypertrophy prevalence was defined as LV mass/height2.7≥51 g/m2.7 LV systolic chamber function was assessed at the midwall using the ratio of observed midwall fractional shortening (MWS%) to the value predicted from circumferential end-systolic stress. Results: The prevalence of LV hypertrophy was 33% in men, 38% in women. The prevalence of concentric hypertrophy (LV hypertrophy with relative wall thickness ≥0.45) was greater than that of eccentric hypertrophy (men: 24% vs 9%; women: 27% vs 11% women). Observed/predicted (O/P) MWS% was strongly and inversely related to LV mass/height2.7 (P<.001) and LV hypertrophy (P<001). The O/P MWS% was inversely related to LV mass/height2.7 quartile: O/P MWS% was 106% and 99% in the first and 97% and 89% in the fourth quartile of LV mass/height2.7 for men and women, respectively. Adjusting for age, adiposity, diabetes, blood pressure, antihypertensive medication use, and smoking did not remove association between O/P MWS% and LV mass/height2.7. Conclusions: LV hypertrophy was highly prevalent in this population-based middle-aged sample of African Americans and was associated with poorer LV systolic chamber function.
KW - African Americans
KW - Cohort Studies
KW - Echocardiography
KW - Left ventricular mass
UR - http://www.scopus.com/inward/record.url?scp=7444240313&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=7444240313&partnerID=8YFLogxK
M3 - Article
C2 - 15724766
AN - SCOPUS:7444240313
VL - 14
SP - 483
EP - 488
IS - 4
ER -